This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1997;53(2):83-8.

doi: 10.1007/s002280050342.

Who cares about pharmacovigilance?

Affiliations

PMID: 9403276
DOI: 10.1007/s002280050342

Who cares about pharmacovigilance?

I R Edwards. Eur J Clin Pharmacol. 1997.

. 1997;53(2):83-8.

doi: 10.1007/s002280050342.

Author

Affiliation

¹ Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring, Sweden.

PMID: 9403276
DOI: 10.1007/s002280050342

No abstract available

PubMed Disclaimer

Similar articles

Pharmacovigilance in the pharmaceutical industry.
Talbot JC, Nilsson BS. Talbot JC, et al. Br J Clin Pharmacol. 1998 May;45(5):427-31. doi: 10.1046/j.1365-2125.1998.00713.x. Br J Clin Pharmacol. 1998. PMID: 9643613 Free PMC article. Review. No abstract available.
Modern methods of pharmacovigilance: detecting adverse effects of drugs.
Norén GN, Edwards IR. Norén GN, et al. Clin Med (Lond). 2009 Oct;9(5):486-9. doi: 10.7861/clinmedicine.9-5-486. Clin Med (Lond). 2009. PMID: 19886114 Free PMC article. Review. No abstract available.
Monitoring and managing adverse drug reactions.
Fincham JE. Fincham JE. Am Pharm. 1992 Feb;NS32(2):74-81. doi: 10.1016/s0160-3450(15)31215-0. Am Pharm. 1992. PMID: 1546634 No abstract available.
[Pharmacovigiance: The spontaneous reporting system in Switzerland].
Schäublin M. Schäublin M. Ther Umsch. 2015 Dec;72(11-12):743-8. doi: 10.1024/0040-5930/a000746. Ther Umsch. 2015. PMID: 26654819 Review. German.
National pharmacovigilance program.
Bavdekar SB, Karande S. Bavdekar SB, et al. Indian Pediatr. 2006 Jan;43(1):27-32. Indian Pediatr. 2006. PMID: 16465003 Review. No abstract available.

See all similar articles

Cited by

A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators.
Garashi HY, Steinke DT, Schafheutle EI. Garashi HY, et al. Ther Innov Regul Sci. 2022 Sep;56(5):717-743. doi: 10.1007/s43441-022-00415-y. Epub 2022 Jun 3. Ther Innov Regul Sci. 2022. PMID: 35657484 Free PMC article.
Recent news about drug risks: application to Canadians.
Hogan V, Turner C. Hogan V, et al. CMAJ. 1998 Oct 6;159(7):845-6; 849-50. CMAJ. 1998. PMID: 9805036 Free PMC article. No abstract available.
Discontinuation reactions associated with SSRIs.
Macdonald L. Macdonald L. CMAJ. 1998 Oct 6;159(7):846-7; 850-2. CMAJ. 1998. PMID: 9805037 Free PMC article. No abstract available.
What can consumer adverse drug reaction reporting add to existing health professional-based systems? Focus on the developing world.
Fernandopulle RB, Weerasuriya K. Fernandopulle RB, et al. Drug Saf. 2003;26(4):219-25. doi: 10.2165/00002018-200326040-00002. Drug Saf. 2003. PMID: 12608886 Review.
Pharmacovigilance in Italy: An overview.
Mazzitello C, Esposito S, De Francesco AE, Capuano A, Russo E, De Sarro G. Mazzitello C, et al. J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S20-8. doi: 10.4103/0976-500X.120942. J Pharmacol Pharmacother. 2013. PMID: 24347976 Free PMC article. Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer